Loading company…
Beijing-based reagent developer making colloidal gold, fluorescent, molecular diagnostic and related reagents and devices.
Pro-med Technology develops diagnostic reagents, including colloidal gold quantitative, fluorescent quantitative and molecular diagnostic reagents, along with related devices. Its range includes over 60 detection reagents and a CWPS thromboelastogram line, and its products have been sold to more than 5,000 medical institutions in over 30 provinces. Established in 2013 in Beijing, China, the company raised venture funding from Zero2IPO Ventures in September 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in